Answers are grounded in this paper and cite their sources.
Inequity has been a hallmark of the COVID-19 pandemic in the United States, especially in the sharply disproportionate impacts among people of color (CDC 2020). Recent studies have confirmed that these disparate impacts do not result from a biologic susceptibility of racial and ethnic minority groups to SARS-CoV-2 but rather from the socioeconomic conditions they face as direct and indirect effects of racism and structural injustice (Ogedegbe et al. 2020). Therefore addressing the impact of racism and inequity is critical to an equitable allocation of the COVID-19 vaccine. Nationally, greater social and economic vulnerability in a particular geographic area is strongly correlated with the risk of becoming a COVID-19 hotspot (Dasgupta et al. 2020). Health disparities and inequities pervade the COVID-19 pandemic. Compared to White, nonHispanic persons, American Indian or Alaskan Natives(AI/AN), Latinx, and Black people are 80%, 70%, and 40% more likely, respectively, to become infected with SARS-CoV-2 (CDC 2020). People of color are also more likely to have serious cases of COVID-19, as AI/AN, Latinx and Black communities are 4 times, 4.1 times, and 3.7 times more likely, respectively, than White people to require hospitalization after a COVID-19 diagnosis (CDC 2020). Compared to White people, AI/AN, Latinx, and Black people are 2.6 times, 2.8 times, and 2.8 times more likely to die of COVID-19 (CDC 2020). The heightened vulnerability of people of color to SARS-CoV-2 exposure reflects their disproportionate presence among low-paid essential workers who lack adequate protection and cannot work from home (Hawkins 2020; McNicholas and Poydock 2020) and among residents of overcrowded living arrangements that facilitate transmission (Ahmad et al. 2020; CDC 2020). Communities of color also experience disproportionate rates of co-morbid conditions that are associated with poorer health outcomes among COVID-19 patients (Quinones et al. 2019). Tragically, racial, ethnic and socioeconomic disparities and inequities in health outcomes are nothing new in this country, as diverse health indicators reveal disparities and inequalities in health care access and outcomes across diverse health indicators (CDC 2013). However, the COVID-19 pandemic has coincided with unprecedented national recognition of the role and impact of racism across multiple domains of American life (Galston 2020). The emergence of multiple safe, effective COVID-19 vaccines affords an opportunity to “get this right”—to ensure that vaccination reaches the most vulnerable communities rather than replicating and reinforcing underlying inequity (McClung et al. 2020). It is clear that “business as usual” will not ensure just and equitable access to COVID-19 vaccination. Too often, new medical breakthroughs have previously served to exacerbate rather than narrow health disparities (Jung and Feldman 2017; Ganguly et al. 2019; Kabria 2019). For example, even though Black people are eight times more likely to be diagnosed with HIV than White people (CDC n.d.), coverage of highly effective HIV pre-exposure prophylaxis (PrEP) is seven times higher among Whites than among Blacks (Harris et al. 2019). It will take determination, innovation, and political and community engagement and leadership to ensure that communities that need COVID-19 vaccination the most have equitable access to it and are motivated to be vaccinated. The most vulnerable communities must be specifically prioritized at each stage of rollout, and the barriers that have long impeded robust uptake of new technologies in underserved communities must be removed. Achieving equity in the allocation of vaccines requires a clear, intensive focus on ensuring robust
No takes yet. Share an insight, caveat, or question.
Gayle et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: